Zum Inhalt

Annals of Hematology

Ausgabe 4/2022

Inhalt (32 Artikel)

A novel SPTB mutation causes hereditary spherocytosis via loss-of-function of β-spectrin

  • Original Article

Shan Li, Ping Guo, Leyuan Mi, Xiaojing Chai, Kewang Xi, Ting Liu, Li Lu, Juan Li

HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia

  • Original Article

Yuan-xin Sun, Qi Feng, Shu-wen Wang, Xin Li, Zi Sheng, Jun Peng

Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy

  • Original Article

Giovanni Caocci, Fabio Efficace, Olga Mulas, Francesco Cottone, Alessia Maxia, Alessandro Costa, Maria Pina Simula, Emilio Usala, Giorgio La Nasa

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis

  • Original Article

Irit Avivi, Chava Perry, Yafit Segman, Odelia Amit, Yaeli Bar-On, Ofrat Beyer Katz, Ronit Gold, Elena Ribakovsky, Abraham Avigdor, Vladimir Vainstein, Neta Goldschmidt, Shimrit Ringelstein-Harlev, Netanel A. Horowitz, Odit Gutwein, Ronit Gurion, Gilad Itchaki, Uri Abadi, Anatoly Nemets, Orit Sofer, Miri Vezker, Tamar Tadmor, Najib Dally, Kalman Filanovsky, Merav Leiba, Nadav Sarid, Noam Benyamini, Efrat Luttwak, Yair Herishanu, Ron Ram

Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma

  • Original Article

Jinqiu Guan, Feifei Sun, Juan Wang, Junting Huang, Suying Lu, Jia Zhu, Xiaoqin Zhu, Huiqiang Huang, Zhongjun Xia, Yi Que, Ruiqing Cai, Zijun Zhen, Xiaofei Sun, Yizhuo Zhang

Identification of CD105 (endoglin) as novel risk marker in CLL

  • Open Access
  • Original Article

Sarah M. Greiner, Melanie Märklin, Samuel Holzmayer, Kübra Kaban, Sophie Meyer, Clemens Hinterleitner, Claudia Tandler, Ilona Hagelstein, Gundram Jung, Helmut R. Salih, Jonas S. Heitmann, Joseph Kauer

90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years

  • Open Access
  • Original Article

Kathrin Rieger, Rosaria De Filippi, Ola Lindén, Andreas Viardot, Georg Hess, Kristina Lerch, Peter Neumeister, Andrea Stroux, Caroline A. Peuker, Antonio Pezzutto, Antonello Pinto, Ulrich Keller, Christian W. Scholz

Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)

  • Original Article

A. Janikova, J. Michalka, R. Chloupkova, N. Kopalova, V. Campr, K. Kamaradova, L. Kren, D. Belada, K. Benesova, J. Dlouha, P. Klener, V. Procházka, H. Mocikova, J. Duras, M. Trneny

Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia–lymphoma

  • Original Article

Akio Onishi, Shigeo Fuji, Shigehisa Kitano, Akiko Miyagi Maeshima, Kinuko Tajima, Junko Yamaguchi, Ichiro Kawashima, Akihisa Kawajiri, Tomonari Takemura, Ayumu Ito, Takashi Tanaka, Keiji Okinaka, Yoshihiro Inamoto, Saiko Kurosawa, Sung-Won Kim, Wataru Munakata, Dai Maruyama, Kensei Tobinai, Takahiro Fukuda

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells

  • Open Access
  • Original Article

Elisabeth K. M. Mack, Sören Hartmann, Petra Ross, Ellen Wollmer, Christoph Mann, Andreas Neubauer, Cornelia Brendel, Jörg Hoffmann

Revisiting the impact of immunoglobulin isotypes in multiple myeloma

  • Original Article

Susan Bal, Smith Giri, Kelly N. Godby, Luciano J. Costa

Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study

  • Original Article

Yue-ying Mao, Hua-cong Cai, Kai-ni Shen, Long Chang, Lu Zhang, Yan Zhang, Jun Feng, Wei Wang, Chen Yang, Tie-nan Zhu, Ming-hui Duan, Dao-bin Zhou, Xin-xin Cao, Jian Li

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations

  • Open Access
  • Original Article

Sayantanee Dutta, Jennifer Moritz, Gudrun Pregartner, Gerhard G. Thallinger, Ilona Brandstätter, Karin Lind, Simin Rezania, Freya Lyssy, Andreas Reinisch, Armin Zebisch, Andrea Berghold, Albert Wölfler, Heinz Sill

3′CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant

  • Original Article

Guilin Tang, Ying Zou, Sa A. Wang, Gautam Borthakur, Gokce Toruner, Shimin Hu, Shaoying Li, Jie Xu, L. Jeffrey Medeiros, Zhenya Tang

Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study

  • Original Article

Federica Martella, Marco Cerrano, Daniela Di Cuonzo, Carolina Secreto, Matteo Olivi, Vincenzo Apolito, Stefano D’Ardia, Chiara Frairia, Valentina Giai, Giuseppe Lanzarone, Irene Urbino, Roberto Freilone, Luisa Giaccone, Alessandro Busca, Chiara Maria Dellacasa, Ernesta Audisio, Dario Ferrero, Eloise Beggiato

A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review

  • Original Article

Mohammad Vaezi, Maryam Souri, Seyed Amin Setarehdan, Amir Ali Hamidieh, Mohammad Reza Fazlollahi, Zahra Pourpak, Mohsen Badalzadeh, Shaghayegh Tajik, Seyed Alireza Mahdaviani, Kamran Alimoghaddam, Ardeshir Ghavamzadeh

Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination

  • Zur Zeit gratis
  • COVID-19
  • Letter to the Editor

Kei Saito, Satoshi Ichikawa, Shunsuke Hatta, Yuna Katsuoka, Hideo Harigae, Tohru Izumi

Falsely elevated serum vitamin B12 levels in a case of pernicious anemia

  • Letter to the Editor

Edwin W. S. Thong, Shaun S. Tan, Sunil K. Sethi, Yen-Lin Chee, Wei-Ying Jen

Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis

  • Letter to the Editor

Damien Luque Paz, Laurane Cottin, Eric Lippert, Jean-Baptiste Robin, Charles Bescond, Franck Genevieve, Françoise Boyer, Isabelle Quintin-Roue, Marie-Christine Rousselet, Barbara Burroni, Mathilde Hunault-Berger, Valérie Ugo, Jean-Christophe Ianotto, Corentin Orvain

Detection of pulse rate elevation by Apple Watch in a patient with bronchiolitis obliterans syndrome after allogeneic stem cell transplantation

  • Letter to the Editor

Toshiki Mushino, Akinori Nishikawa, Takayuki Hiroi, Yoriko Matsuyama, Hiroki Hosoi, Shogo Murata, Shinobu Tamura, Takashi Sonoki

T-cell receptor-silent peripheral T-cell lymphoma complicated with hemophagocytic lymphohystiocytosis

  • Letter to the Editor

Koya Ono, Yasushi Onishi, Koichi Onodera, Daigo Michimata, Eijiro Furukawa, Kazuki Sakurai, Naoya Morota, Takumi Sawada, Satoshi Ichikawa, Noriko Fukuhara, Hisayuki Yokoyama, Hirofumi Watanabe, Chie Suzuki, Hideo Harigae

Need for integrating early palliative care with standard hematology care long before the allogeneic hemopoietic stem cells transplantation

  • Letter to the Editor

Leonardo Potenza, Eleonora Borelli, Sarah Bigi, Vittorio Ganfi, Mario Luppi, Elena Bandieri

Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenita

  • Letter to the Editor

Eugene Brailovski, Hubert Tsui, Yi-Bin Chen, Lea Velsher, Jiajia Liu, Rena Buckstein

The incidental discovery of a constitutional trisomy 21 mosaicism in an adult female with myelodysplastic/myeloproliferative neoplasm

  • Open Access
  • Letter to the Editor

Samantha O’Hagan Henderson, Anita Glaser, Jochen J. Frietsch, Andreas Hochhaus, Inken Hilgendorf

A rare de novo pure erythroid leukemia with JAK2 R683S mutation

  • Letter to the Editor

Rebecca Z Xu, Aly Karsan, Zhaodong Xu, Brian R. Berry

Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil

  • Zur Zeit gratis
  • COVID-19
  • Letter to the Editor

Evandro M. Fagundes, Naira N. Neto, Lorena M. Caldas, Jordana R. Aragão, Ana Beatriz F. Gloria, Leonardo G. Leite, Paula Bastos, Carolina M. Fernandes, Mariana Chalup, Rosa Arcuri, Olivia G. Fagundes

Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination

  • Open Access
  • Letter to the Editor

Marcel Kemper, Christoph Berssenbrügge, Georg Lenz, Rolf Michael Mesters

Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis

  • Zur Zeit gratis
  • COVID-19
  • Letter to the Editor

Giovanni Caocci, Olga Mulas, Daniela Mantovani, Alessandro Costa, Andrea Galizia, Luca Barabino, Marianna Greco, Roberta Murru, Giorgio La Nasa

Association of blood type A with increased risk of severe COVID-19 in healthcare workers

  • Zur Zeit gratis
  • COVID-19
  • Letter to the Editor

Niraj N. Mahajan, Rahul K. Gajbhiye, Periyasamy Kuppusamy, Shubhada Bahirat, Pradip D. Lokhande

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Fokale Salvage-Therapie bei lokalem Prostatakrebsrezidiv langfristig wirksam

Bei einem nach Radiotherapie lokal rezidivierten Prostatakarzinom sind fokale Salvage-Therapien mit einer guten Prognose verbunden: Das krebsspezifische Zehn-Jahres-Überleben ist einem retrospektiven Vergleich zufolge ebenso hoch wie nach Salvage-Prostatektomie.

Relacorilant verlängert Überleben bei platinresistentem Ovarialkarzinom

Durch Hinzunahme des Glukokortikoid-Rezeptor-Antagonisten Relacorilant zu nab-Paclitaxel wird bei Frauen mit platinresistentem Ovarialkarzinom nicht nur das progressionsfreie, sondern auch das Gesamtüberleben verlängert. Laut finaler Analyse der ROSELLA-Studie gewinnen sie vier Monate an Lebenszeit.

ICI-induzierte Dermatitis: Upadacitinib als vielversprechende Therapieoption

Immunvermittelte Hautreaktionen gehören zu den häufigsten Nebenwirkungen von Immun‑Checkpoint‑Inhibitoren. Eine offene Phase‑2‑Studie untersuchte den JAK‑1‑Inhibitor Upadacitinib bei schwerer ICI‑assoziierter Dermatitis. Die Hautsymptome gingen rasch zurück, schwerwiegende therapieassoziierte Nebenwirkungen wurden nicht beobachtet.

Extrapulmonale Befunde beim Lungenkrebs-Screening – Krebsverdacht gerechtfertigt?

Der Umgang mit Zufallsentdeckungen ist ein vieldiskutiertes Thema im Zusammenhang mit dem Low-Dose-CT-Screening auf Lungenkrebs. Eine Studie hat sich nun speziell mit inzidentellen Befunden befasst, die auf ein extrapulmonales Malignom verdächtig sind.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Eine Person kratzt sich am Rücken über der Schulter/© ryanking999 / stock.adobe.com (Symbolbild mit Fotomodell), Mann erhält einen CT-Scan /© Mark Kostich / stock.adobe.com (Symbolbild mit Fotomodell)